ZBD Pharmaceuticals' shareholder Huzhou Saihan reduced its holdings, bringing its stake down to 5%

Heilongjiang Zhenbao Island Pharmaceutical announced that its shareholder Huzhou Saihan, holding more than 5% of the shares, has implemented a reduction plan, reducing 48,354 shares through centralized bidding on September 10. Previously, due to the company's repurchase and cancellation of restricted stocks, Huzhou Saihan's shareholding ratio increased passively. After this change in equity, its holdings decreased to 47,049,826 shares, and the ratio fell to 5%, no longer qualifying as a shareholder holding more than 5%. This change does not trigger a tender offer and does not alter the company's controlling rights. The reduction plan has not been fully implemented, and the company will closely monitor the progress and urge disclosure